Trials (Instituto Português de Oncologia de Lisboa Francisco Gentil): Revision history

15 December 2025

• curprev 13:3213:32, 15 December 2025‎ Francine talk contribs‎ 15,504 bytes +217‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 15,287 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 15:2215:22, 4 December 2025‎ Larysse talk contribs‎ 13,586 bytes +50‎ No edit summary undo

2 December 2025

• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 13,536 bytes +90‎ Update categories. undo

5 December 2023

• curprev 14:1614:16, 5 December 2023‎ Francine talk contribs‎ 13,446 bytes +13,446‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia de Lisboa Francisco Gentil page '''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versu..."